Insights into the Mechanisms of Immune‐Checkpoint Inhibitors Gained from Spatiotemporal Dynamics of the Tumor Microenvironment
Advanced Science · 2025-09 · 12 (36)
DOI: 10.1002/advs.202508692 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 28.08.2025. Verfasst von Yuanyuan Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of M…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Immune Checkpoint Inhibitors, Neoplasms, Immunotherapy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 351 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Medical Research Funds, National Natural Science Foundation of China, Beijing Nova Program, the CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Immunotherapy, particularly immune checkpoint inhibitors (ICIs), has revolutionized cancer treatment, yet durable responses are achieved in only a subset of patients. The tumor microenvironment (TME) plays a key role in cancer progression and immune modulation, critically influencing the efficacy of ICIs. Recent advances in single‐cell technologies have enabled high‐resolution profiling of the TME, particularly tumor‐infiltrating immune cells, across diverse cancer types. However, our understanding of how immune cells shape ICI responses and how they are dynamically altered during treatment remains incomplete. In this review, we summarize recent progress in characterizing TME features associated with ICI responsiveness, highlighting key immune cell subsets involved in ICI therapy and emphasizing their phenotypic plasticity and functional adaptability following ICIs. Additionally, we outline the spatial architecture of the TME in terms of its effects on immune cell behavior and interactions, and discuss the critical role of stromal components and the microbiota in modulating the immune landscape and influencing ICI responsiveness. By integrating these insights, we aim to deepen our understanding of the cellular and molecular mechanisms underlying ICI responses, elucidate determinants of therapeutic sensitivity and resistance, and inform the development of more effective immunotherapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, Chi…
ORCID-Profile: Zhihua Liu
Förderung
- Shenzhen Medical Research Funds
- National Natural Science Foundation of China
- Beijing Nova Program, the CAMS Innovation Fund for Medical Sciences
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
Zitieren
APA
Zhang, Y., & Liu, Z. (2025). Insights into the Mechanisms of Immune‐Checkpoint Inhibitors Gained from Spatiotemporal Dynamics of the Tumor Microenvironment. Advanced Science, 12(36). https://doi.org/10.1002/advs.202508692
Vancouver
Zhang Y, Liu Z. Insights into the Mechanisms of Immune‐Checkpoint Inhibitors Gained from Spatiotemporal Dynamics of the Tumor Microenvironment. Advanced Science. 2025;12(36). doi:10.1002/advs.202508692
BibTeX
@article{Zhang2025,
author = {Zhang, Yuanyuan and Liu, Zhihua},
title = {Insights into the Mechanisms of Immune‐Checkpoint Inhibitors Gained from Spatiotemporal Dynamics of the Tumor Microenvironment},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {36},
doi = {10.1002/advs.202508692}
}
EUVIMED